IDO1 and colorectal cancer: Concordant to this, previous research on colorectal cancer found immune checkpoint expression of PD-1, PD-L1, CTLA-4, LAG-3, and IDO as a counterbalancing part of highly inflamed tumors (MSI unstable) [42].